Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

Renal Urokinase-Type Plasminogen Activator (uPA) Receptor but not uPA Deficiency Strongly Attenuates Ischemia Reperfusion Injury and Acute Kidney Allograft Rejection

(2014) F. Gueler et al.   JOURNAL OF IMMUNOLOGY

Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain

(2013) S. Lyngbaek et al.   CLINICAL CHEMISTRY

Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes

(2013) F. S. Siddiqi et al.   DIABETES

The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status

(2013) A. Heraclides et al.   DIABETOLOGIA

Arterial Stiffness Is Associated With Cardiovascular, Renal, Retinal, and Autonomic Disease in Type 1 Diabetes

(2012) S. Theilade et al.   DIABETES CARE

Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes

(2012) S. Theilade et al.   DIABETIC MEDICINE

Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score

(2012) Stig Lyngbæk et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

CRP and suPAR are differently related to anthropometry and subclinical organ damage

(2012) Stig Lyngbæk et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity

(2012) Luc M. Van Bortel et al.   JOURNAL OF HYPERTENSION

Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study

(2011) M. Persson et al.   ATHEROSCLEROSIS

The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome

(2011) Gürdal Yilmaz et al.   CLINICAL BIOCHEMISTRY

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria

(2011) B. Zhang et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evolution and predictors of morphological and functional arterial changes in the course of type 1 diabetes mellitus

(2010) Ildikó Vastagh et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

(2008) A. S. Astrup et al.   DIABETES CARE

Urokinase and its receptors in chronic kidney disease

(2008) Guoqiang Zhang   Frontiers in Bioscience-Landmark

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

(2007) Debbie A. Lawlor et al.   STATISTICS IN MEDICINE